Search Results - "rifampicin"

Resistência a isoniazida e rifampicina e história de tratamento anterior para tuberculose Isoniazid and rifampicin resistance and prior treatment for tuberculosis by Sonia Natal, Joaquim Gonçalves Valente, Alexandra Roma Sánchez, Maria Lúcia Fernandes Penna

Connect to this object online.

Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of <i>Mycobacterium tuberculosis</i> Infection by Laura Sibley, Andrew D. White, Charlotte Sarfas, Jennie Gullick, Fergus Gleeson, Faye Lanni, Simon Clark, Emma Rayner, Santiago Ferrer-Bazaga, Fatima Ortega-Muro, Laura Alameda, Joaquin Rullas, Veronica Sousa, Marisa Martinez, Inigo Angulo-Barturen, Adolfo Garcia, Juan José Vaquero, Henry E. Pertinez, Geraint Davies, Mike Dennis, Ann Williams, Sally Sharpe

Connect to this object online.

Robust physiologically based pharmacokinetic model of rifampicin for predicting drug-drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney by Ryuta Asaumi, Ken‐ichi Nunoya, Yoshiyuki Yamaura, Kunal S. Taskar, Yuichi Sugiyama

Connect to this object online.

Early Staphylococcal Periprosthetic Joint Infection (PJI) Treated with Debridement, Antibiotics, and Implant Retention (DAIR): Inferior Outcomes in Patients with Staphylococci Resistant to Rifampicin by Hannah K. Eriksson, Stergios Lazarinis, Josef D. Järhult, Nils P. Hailer

Connect to this object online.

Whole-genome sequencing for surveillance of fluoroquinolone resistance in rifampicin-susceptible tuberculosis in a rural district of Shanghai: A 10-year retrospective study by Yangyi Zhang, Yangyi Zhang, Yangyi Zhang, Yuan Jiang, Yuan Jiang, Chenlei Yu, Chenlei Yu, Jing Li, Jing Li, Xuhui Shen, Xuhui Shen, Qichao Pan, Qichao Pan, Xin Shen, Xin Shen

Connect to this object online.

High-Dose Rifampicin Mediated Systemic Alterations of Cytokines, Chemokines, Growth Factors, Microbial Translocation Markers, and Acute-Phase Proteins in Pulmonary Tuberculosis by Gokul Raj Kathamuthu, Perumal Kannabiran Bhavani, Manjula Singh, Jitendra Kumar Saini, Ashutosh Aggarwal, Mohammed Soheb S. Ansari, Rajiv Garg, Subash Babu, Subash Babu

Connect to this object online.

Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa by Katherine C. McNabb, Alanna J. Bergman, Amita Patil, Kelly Lowensen, Nomusa Mthimkhulu, Chakra Budhathoki, Nancy Perrin, Jason E. Farley

Connect to this object online.

Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective by Agnija Kivrane, Viktorija Ulanova, Solveiga Grinberga, Eduards Sevostjanovs, Anda Viksna, Iveta Ozere, Ineta Bogdanova, Maksims Zolovs, Renate Ranka

Connect to this object online.

Cluster Gauss‐Newton method analyses of PBPK model parameter combinations of coproporphyrin‐I based on OATP1B‐mediated rifampicin interaction studies by Takashi Yoshikado, Yasunori Aoki, Tatsuki Mochizuki, A. David Rodrigues, Koji Chiba, Hiroyuki Kusuhara, Yuichi Sugiyama

Connect to this object online.

Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter? by Glauco Henrique Balthazar Nardotto, Elin M. Svenson, Valdes Roberto Bollela, Adriana Rocha, Svetoslav Nanev Slavov, João Paulo Bianchi Ximenez, Oscar Della Pasqua, Vera Lucia Lanchote

Connect to this object online.

The clinical impact of rifampicin-based anti-TB therapy and tenofovir alafenamide-containing ARV regimen drug Interaction in people living with HIV: Case series report by Yahya Ali Mohzari, Mohammed AL Musawa, Ahmad Alrashed, Bandar Zaeri, Nader Damfu, Peter Cahusac, Sana Alwafai, Ahmad Alamer, Abdulaziz Almulhim

Connect to this object online.

The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study by Peter J Dodd, ProfPhD, Nyashadzaishe Mafirakureva, PhD, James A Seddon, PhD, Christopher F McQuaid, PhD

Connect to this object online.

Physiologically‐Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and Midazolam by Hannah Britz, Nina Hanke, Anke‐Katrin Volz, Olav Spigset, Matthias Schwab, Thomas Eissing, Thomas Wendl, Sebastian Frechen, Thorsten Lehr

Connect to this object online.

Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India by Ravibalan Thirumurugan, Maruthai Kathirvel, Kommoju Vallayyachari, Kesavan Surendar, Antony V. Samrot, Muthuraj Muthaiah

Connect to this object online.

Do High Doses of Multiple Antibiotics Loaded into Bone Cement Spacers Improve the Success Rate in Staphylococcal Periprosthetic Joint Infection When Rifampicin Cannot Be Employed? by Lourdes Prats-Peinado, Tanya Fernández-Fernández, Miguel Márquez-Gómez, José Antonio Matas-Diaz, Mar Sánchez-Somolinos, Sofía de la Villa-Martínez, Javier Vaquero-Martín, Pablo Sanz-Ruiz

Connect to this object online.

Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P‐glycoprotein-cytochrome P450 3A4 dual substrates by Xian Pan, Shinji Yamazaki, Sibylle Neuhoff, Mian Zhang, Venkatesh Pilla Reddy

Connect to this object online.

Expanded Physiologically‐Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction by Ryuta Asaumi, Karsten Menzel, Wooin Lee, Ken‐ichi Nunoya, Haruo Imawaka, Hiroyuki Kusuhara, Yuichi Sugiyama

Connect to this object online.

Evaluation of whole-genome sequence to predict drug resistance of nine anti-tuberculosis drugs and characterize resistance genes in clinical rifampicin-resistant Mycobacterium tuberculosis isolates from Ningbo, China by Yang Che, Yi Lin, Tianchi Yang, Tong Chen, Guoxin Sang, Qin Chen, Tianfeng He

Connect to this object online.

Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of <it>Escherichia coli </it>O157:H7-infected BALB/c mice by Abdelnoor Alexander M, Sabra Ahmad, Kazzi Natalie, Rahal Elias A, Matar Ghassan M

Connect to this object online.

A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial by William M. Hague, Leonie Callaway, Jennifer Chambers, Lucy Chappell, Suzette Coat, Jiska de Haan-Jebbink, Marloes Dekker, Peter Dixon, Jodie Dodd, Maria Fuller, Sanne Gordijn, Dorothy Graham, Oskari Heikinheimo, Annemarie Hennessy, Risto Kaaja, Teck Yee Khong, Laura Lampio, Jennie Louise, Angela Makris, Corey Markus, Hanns-Ulrich Marschall, Philippa Middleton, Ben W. Mol, Jonathan Morris, John P. Newnham, Caroline Ovadia, Michael Peek, Antonia Shand, Michael Stark, Jim Thornton, Susanna Timonen, Susan Walker, David Warrilow, Catherine Williamson

Connect to this object online.